{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:21:12Z","timestamp":1791048072223,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,24]],"date-time":"2016-04-24T00:00:00Z","timestamp":1461456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Swedish Cancer Foundation to TL"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jdermsci.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T23:59:43Z","timestamp":1462060783000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis"],"prefix":"10.1016","volume":"83","author":[{"given":"Martin","family":"Stenstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hel\u00e9n Carlsson","family":"Nyhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"T\u00f6rngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sparre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hel\u00e9n","family":"Tuvesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Leanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0010","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1186\/1755-1536-5-S1-S19","article-title":"Molecular targets for therapy in systemic sclerosis","volume":"5","author":"Iwamoto","year":"2012","journal-title":"Fibrogenes. Tissue Repair"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/CS20130367","article-title":"Innate immunity in systemic sclerosis pathogenesis","volume":"126","author":"O\u2019Reilly","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0025","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03009742.2012.736532","article-title":"Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjogren\u2019s syndrome antigens and nuclear ribonucleoprotein antigens","volume":"42","author":"Wuttge","year":"2013","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0035","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthr. Res. Ther."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0040","first-page":"1202","article-title":"Macrophage infiltration in the skin of patients with systemic sclerosis","volume":"19","author":"Ishikawa","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0050","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/jm031044w","article-title":"Synthesis and biological evaluation of new 1 2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship","volume":"47","author":"Jonsson","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0055","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ajpath.2013.01.032","article-title":"Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells","volume":"182","author":"Helmersson","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0060","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.33493","volume":"64","author":"Bengtsson","year":"2012","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2013.02.023","article-title":"Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice","volume":"228","author":"Yan","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.intimp.2013.12.008","article-title":"The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: leukocyte- and context-specific effects","volume":"18","author":"Deronic","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0075","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","article-title":"Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides","volume":"7","author":"Bjork","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1600-0625.2012.01571.x","article-title":"Novel insights into the role of S100A8\/A9 in skin biology","volume":"21","author":"Kerkhoff","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","article-title":"Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation","volume":"344","author":"Foell","year":"2004","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0090","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Nikitorowicz-Buniak","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10067-013-2305-4","article-title":"Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities","volume":"32","author":"Xu","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.intimp.2011.02.025","article-title":"Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cells","volume":"11","author":"Helmersson","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0105","doi-asserted-by":"crossref","first-page":"e33797","DOI":"10.1371\/journal.pone.0033797","article-title":"Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity","volume":"7","author":"Schulze-Topphoff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","article-title":"Animal model of systemic sclerosis","volume":"37","author":"Yamamoto","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0120","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","article-title":"Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice","volume":"166","author":"Mack","year":"2001","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0125","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","article-title":"Animal models of systemic sclerosis: prospects and limitations","volume":"62","author":"Beyer","year":"2010","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2249.2004.02633.x","article-title":"Autoantibodies to a collagen-specific molecular chaperone, heat-shock protein 47, in systemic sclerosis","volume":"138","author":"Fujimoto","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0135","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1432-1033.2004.04129.x","article-title":"Fibroblast growth-stimulating activity of S100A9 (MRP-14)","volume":"271","author":"Shibata","year":"2004","journal-title":"Eur. J. Biochem.\/FEBS"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0140","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2004-02-0446","article-title":"MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes","volume":"104","author":"Vogl","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0145","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/art.21396","article-title":"Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation","volume":"52","author":"Carulli","year":"2005","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0150","doi-asserted-by":"crossref","first-page":"12053","DOI":"10.1073\/pnas.94.22.12053","article-title":"Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2","volume":"94","author":"Kuziel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0155","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.4049\/jimmunol.167.8.4368","article-title":"Protection from pulmonary fibrosis in the absence of CCR2 signaling","volume":"167","author":"Moore","year":"2001","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0160","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","article-title":"CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2\/CCR2-dependent gene expression profile","volume":"192","author":"Sierra-Filardi","year":"2014","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0165","doi-asserted-by":"crossref","first-page":"L313","DOI":"10.1152\/ajplung.00434.2002","article-title":"Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung","volume":"285","author":"Endo","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-015-0098-5","article-title":"Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment","volume":"3","author":"Olsson","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0175","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2326-6066.CIR-14-0036","article-title":"Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models","volume":"3","author":"Shen","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0180","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","article-title":"Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"163","author":"McCormick","year":"1999","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0185","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4049\/jimmunol.179.1.698","article-title":"Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice","volume":"179","author":"Matsushita","year":"2007","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0190","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/annrheumdis-2012-201784","article-title":"Pomalidomide is effective for prevention and treatment of experimental skin fibrosis","volume":"71","author":"Weingartner","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2016.04.006_bib0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/sji.12152","article-title":"Quinoline-3-carboxamides modulate primary T cell-dependent B cell responses but do not inhibit functional immunity","volume":"79","author":"Kallberg","year":"2014","journal-title":"Scand. J. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T21:25:10Z","timestamp":1692307510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116300615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0923181116300615"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.04.006","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ireland Ltd on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}